Crizalk 200mg Capsule
Marketer
Pfizer Ltd
Salt Composition
Crizotinib (200mg)
Overview Crizalk 200mg Capsule
Alectinib 200mg capsules treat advanced non-small cell lung cancer, including metastatic disease. Administer this medication with or without food, consistently at the same time daily for optimal effectiveness. Dosage and frequency are determined by your physician based on your condition and may vary. Follow your doctor's instructions precisely; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects may not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include nausea, vomiting, swelling, and diarrhea. Seek immediate medical attention for serious side effects such as intense abdominal pain, fever, chills, respiratory distress, rapid pulse, vision impairment, or altered bowel movements. Your doctor may order blood tests to monitor liver function. Inform your physician of any pre-existing heart, liver, or kidney conditions, or concurrent medications, especially anti-infectives, before starting treatment. This medication interacts with many other drugs; disclose all medications to your healthcare provider. Avoid pregnancy during treatment; effective contraception is crucial for both partners. A patient assistance program is available in India, administered by Tata 1mg. Contact your doctor or call (1800-102-1618) for further information.
Uses of Crizalk 200mg Capsule
Lung cancer (excluding small cell)
Major Benefits of Crizalk 200mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Crizalk 200mg Capsules. These capsules can be ingested with or without food, however, consistent daily timing is recommended.
Common Side effects of Crizalk 200mg Capsule:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal pain
- Visual impairment
- Dizziness
- Taste change
- Fatigue
- Decreased appetite
- Rash
- Decreased white blood cell count (neutrophils)
How to use Crizalk 200mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Crizalk 200mg Capsules can be ingested with or without food; however, consistent daily timing is recommended.
How Crizalk 200mg Capsule works:
Oncaspar 200mg capsules are a cancer treatment. Their mechanism involves inhibiting the activity of a faulty protein responsible for cancerous cell proliferation. This action contributes to halting or decelerating cancer progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol and Crizalk 200mg Capsules is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Crizalk 200mg capsules is contraindicated during pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Nursing mothers should likely avoid Crizalk 200mg capsules. Available evidence indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a 200mg Crizalk capsule can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
For individuals with severe kidney impairment, administration of Crizalk 200mg Capsules requires careful monitoring. Dosage modification of Crizalk 200mg Capsules may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Crizalk 200mg capsules cautiously, potentially requiring dosage modification. Consult a physician for guidance. Crizalk 200mg capsules may be unsuitable for individuals with severe hepatic dysfunction.
What if you forget to take Crizalk 200mg Capsule :
Omit any missed Crizalk 200mg Capsule dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Crizalk 200mg Capsule
| Label | Value |
|---|---|
| Chemical Type | Piperidine and Aminopyridine Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently
